Ezetimibe lowers LDL cholesterol by inhibiting the Niemann-Pick C1-Like 1 (NPC1L1) protein in the intestines.
This protein is responsible for cholesterol absorption, and blocking it reduces cholesterol uptake into the bloodstream.
Ezetimibe is often used in combination with statins for enhanced lipid-lowering effects.